The value of intravascular ultrasound in patients with acute myocardial infarction
Romanian Journal of Cardiology · 2022
DOI: 10.2478/rjc-2022-0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Cardiology, 2022. Verfasst von Alexandru Petrinel Cîrjan und 5 weiteren Autor:innen. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Defining the best percutaneous coronary intervention (PCI) in acute myocardial infarction is sometimes difficult, bearing in mind that time is of the essence in preventing myocardial tissue damage. There are invasive modalities to determine the best strategy. These include intravascular ultrasound (IVUS) and optical coherence tomography (OCT), methods that could underline plaque rupture, thrombus, positive remodeling, greater plaque burden, and tissue prolapse. Virtual histology IVUS is capable of detecting lesions containing large necrotic cores and thin cap fibroatheroma (independent predictors of no-reflow in acute myocardial patients). Using these imagistic modalities can lead the PCI strategy in order to obtain the best possible outcome of the procedure for the patient.
Zitieren
APA
Cîrjan, A. P., Kulcsar, I. D., Stavaru, R., Catana, N., Deleanu, D., & Predescu, L. M. (2022). The value of intravascular ultrasound in patients with acute myocardial infarction. Romanian Journal of Cardiology. https://doi.org/10.2478/rjc-2022-0013
Vancouver
Cîrjan AP, Kulcsar ID, Stavaru R, Catana N, Deleanu D, Predescu LM. The value of intravascular ultrasound in patients with acute myocardial infarction. Romanian Journal of Cardiology. 2022. doi:10.2478/rjc-2022-0013
BibTeX
@article{Crjan2022,
author = {Cîrjan, Alexandru Petrinel and Kulcsar, Iulia Daniela and Stavaru, Radu and Catana, Nicu and Deleanu, Dan and Predescu, Lucian Marius},
title = {The value of intravascular ultrasound in patients with acute myocardial infarction},
journal = {Romanian Journal of Cardiology},
year = {2022},
doi = {10.2478/rjc-2022-0013}
}
EUVIMED